Affymax and Takeda Confirm U.S. Registration Strategy for Investigational Drug ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
"Our plan is to pursue approval of peginesatide for the treatment of anemia in CRF patients on dialysis," said Arlene M. Morris, chief executive officer of

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.